Adnan Alseidi
Overview
Explore the profile of Adnan Alseidi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
184
Citations
1313
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yin H, Sharma D, Wang J, Ganjouei A, Kouanda A, Hirose K, et al.
Chin Clin Oncol
. 2025 Mar;
14(1):5.
PMID: 40081386
Malignant duodenal obstruction is a common issue affecting up to 20% of patients with advanced gastrointestinal malignancies. Distal duodenal obstruction (DDO) poses unique surgical challenges, such as the need to...
2.
Augustinus S, Sijberden J, Bieze M, Agarwal V, Aldrighetti L, Alseidi A, et al.
BJS Open
. 2025 Mar;
9(1).
PMID: 40036750
Background: Patients undergoing hepato-pancreato-biliary surgery are typically preoperatively assessed using the American Society of Anesthesiologists (ASA) classification, which is also used for case-mix adjustment when comparing centre outcomes. Studies determining...
3.
Rompen I, Stoop T, van Roessel S, van Veldhuisen E, Janssen Q, Alseidi A, et al.
Ann Surg
. 2025 Jan;
PMID: 39886770
Aim: To validate the prognostic value of the PAncreatic NeoAdjuvant MAssachusetts (PANAMA)-score and to determine its predictive ability for survival benefit derived from adjuvant treatment in patients after resection of...
4.
Ejie J, Ganjouei A, Hernandez S, Wang J, Romero-Hernandez F, Foroutani L, et al.
Cancers (Basel)
. 2025 Jan;
17(2).
PMID: 39857951
(1) Background: Comprehensive evaluation of guideline-concordant care (GCC) across all PDAC stages has yet to be thoroughly conducted. This study aimed to characterize treatment patterns and assess factors associated with...
5.
Stoop T, Sugawara T, Oba A, Feld I, van Roessel S, van Veldhuisen E, et al.
JAMA Oncol
. 2025 Jan;
PMID: 39847363
Importance: The effect of adjuvant chemotherapy following resection of pancreatic adenocarcinoma after preoperative (m)FOLFIRINOX (combination leucovorin calcium [folinic acid], fluorouracil, irinotecan hydrochloride, and oxaliplatin in full or modified dosing) chemotherapy...
6.
Mavani P, Sok C, Eng N, Marra A, Foroutani L, Alseidi A, et al.
J Am Coll Surg
. 2025 Jan;
PMID: 39831703
Introduction: Pancreatoduodenectomy (PD) may occasionally be indicated for complete removal of periampullary (duodenal and ampullary) adenomas (PAs). As compared with malignant indications, PD for benign or pre-malignant disease is often...
7.
Uijterwijk B, Moekotte A, Boggi U, Mazzola M, Groot Koerkamp B, Dalle Valle R, et al.
HPB (Oxford)
. 2025 Jan;
27(3):318-329.
PMID: 39765373
Background: Ampullary adenocarcinoma (AAC) typically presents at an early stage due to biliary obstruction and therefore might be specifically suitable for minimally invasive pancreatoduodenectomy (MIPD). However, studies assessing MIPD specifically...
8.
Foroutani L, Ganjouei A, Wang J, Aburayya B, Corvera C, Alseidi A, et al.
Ann Surg Oncol
. 2024 Dec;
32(2):1251-1252.
PMID: 39627640
No abstract available.
9.
Foroutani L, Ganjouei A, Wang J, Aburayya B, Corvera C, Alseidi A, et al.
Ann Surg Oncol
. 2024 Nov;
32(2):1218-1219.
PMID: 39527157
Background: Leiomyomas are benign smooth muscle tumors found at the gastroesophageal junction (GEJ) ( Mathew G, Osueni A, Carter YM. Esophageal Leiomyoma. StatPearls. StatPearls Publishing Copyright © 2024, StatPearls Publishing...
10.
Varas J, Belmar F, Fuentes J, Vela J, Contreras C, Letelier L, et al.
J Surg Educ
. 2024 Oct;
81(12):103302.
PMID: 39442366
Objective: This study aims to assess the effectiveness of training medical students to perform two clinical procedures using unsupervised simulation with remote asynchronous feedback, compared to an intensive workshop with...